NCT01478412

An Evaluation of Polymer Based Fiducials for Use in Imaging Patients Receiving Treatment for Prostate Cancer

A Prospective Evaluation of Polymer Based Fiducials for Use in Imaging Patients Receiving Treatment for Prostate Cancer

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 20 (estimated)
• Sponsor: John Chang, MD · Academic / Other
• Sex: Male
• Age: —
• Healthy volunteers: Not accepted

Summary

This trial is to determine if prostate target delineation obtained through an ultrasound based system is equivalent in accuracy to the MRI image fusion, and if alignment correction vectors obtained from ultrasound imaging are of equivalent accuracy to orthogonal X-ray imaging for daily prostate positioning.

Detailed description

The investigators will also be assessing the following: 1. Whether polymer-based markers can be adequately visualized on daily stereoscopic imaging compared to gold seed markers. 2. Whether polymer-based markers are visible on ultrasound imaging. 3. To determine if the polymer-based marker produces fewer artifacts on treatment planning CT scans than gold markers.

Conditions

• Prostate Adenocarcinoma

Interventions

Type	Name	Description
OTHER	Polymer based fiducial placement	Fiducial marker placement with rectal ultrasound imaging.

Timeline

• Start date: 2011-12-01
• First posted: 2011-11-23
• Last updated: 2011-12-07

Locations

1 site across 1 country: United States